Technical Analysis for ZLAB - Zai Lab Limited

Grade Last Price % Change Price Change
D 24.00 -4.99% -1.26
ZLAB closed down 4.99 percent on Thursday, September 28, 2023, on 78 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Gapped Down Weakness 0.00%
Pocket Pivot Bullish Swing Setup -4.99%
Gapped Up Strength -4.99%
Up 3 Days in a Row Strength -4.99%
Up 4 Days in a Row Strength -4.99%
Oversold Stochastic Weakness -4.99%
Stochastic Buy Signal Bullish -3.69%
Up 3 Days in a Row Strength -3.69%
Gapped Down Weakness -3.69%
Oversold Stochastic Weakness -3.69%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 14 hours ago
Fell Below Lower Bollinger Band about 14 hours ago
Lower Bollinger Band Support about 14 hours ago
Down 1 ATR about 14 hours ago
Gapped Down (Full) about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zai Lab Ltd, incorporated on March 28, 2017, is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Natural Sciences Infectious Diseases Medication Chemical Substances Autoimmune And Infectious Diseases Omadacycline

Is ZLAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.81
52 Week Low 20.98
Average Volume 416,627
200-Day Moving Average 32.52
50-Day Moving Average 26.23
20-Day Moving Average 25.79
10-Day Moving Average 24.97
Average True Range 1.41
RSI (14) 41.52
ADX 10.28
+DI 22.95
-DI 30.31
Chandelier Exit (Long, 3 ATRs) 25.41
Chandelier Exit (Short, 3 ATRs) 26.92
Upper Bollinger Bands 28.19
Lower Bollinger Band 23.39
Percent B (%b) 0.13
BandWidth 18.61
MACD Line -0.40
MACD Signal Line -0.29
MACD Histogram -0.1069
Fundamentals Value
Market Cap 2.11 Billion
Num Shares 88 Million
EPS -3.12
Price-to-Earnings (P/E) Ratio -7.70
Price-to-Sales 268.12
Price-to-Book 20.60
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.33
Resistance 3 (R3) 25.33 24.89 25.11
Resistance 2 (R2) 24.89 24.56 24.89 25.03
Resistance 1 (R1) 24.45 24.35 24.23 24.44 24.96
Pivot Point 24.01 24.01 23.90 24.01 24.01
Support 1 (S1) 23.56 23.67 23.34 23.56 23.04
Support 2 (S2) 23.12 23.46 23.12 22.97
Support 3 (S3) 22.68 23.12 22.89
Support 4 (S4) 22.67